Scleroderma (overview)M34.9

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 10.01.2023

Dieser Artikel auf Deutsch

Synonym(s)

Scleroderma

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Diseases from the classic "fibrotic" form, whereby systemic scleroderma (systemic sclerosis) can be regarded as a prototype of multisystem sclerosis. Circumscribed localized scleroderma is a mono-organic (skin) infection. The leading symptom of scleroderma is the fibrotic remodelling (sclerosis) of the skin.

ClassificationThis section has been translated automatically.

Basically one can distinguish:

  • Circumscribed (or localized) scleroderma: in this case, sclerosis and atrophy are predominantly confined to the skin, the subcutaneous adipose tissue and, depending on the location, also to the underlying bone.
  • Systemic scleroderma (systemic sclerosis), a multi-organ disease with a progressive, potentially fatal course, affecting numerous internal organs in addition to the skin (especially the digestive tract, lungs, vessels, heart and kidneys).

For differential diagnostic reasons, disease patterns with a scleroderma-like aspect or course must be separated, the pseudoscleroderma.

TherapyThis section has been translated automatically.

LiteratureThis section has been translated automatically.

  1. Fabris M, Hunzelmann N (2007) Differential diagnosis of scleroderma and pseudoscleroderma. JDDG 11:977-984
  2. Kayser C et al(2015) Autoantibodies in systemic sclerosis: unanswered questions. Front Immunol 6:167

Authors

Last updated on: 10.01.2023